About Shahid Ghazi Pharmaceutical Company (شرکت داروسازی شهید قاضی)

Shahid Ghazi Pharmaceutical Company (public joint stock) was established after the Islamic Revolution of Iran in line with the policies of changing the structure of the country's pharmaceutical system in terms of ownership, production and distribution, and moving this industry towards self-sufficiency and independence. The company was founded in 1984 and started operation in February 1991. It produces various types of sterile injectable solutions and washes for human and veterinary use, as well as distilled water ampoules.

Vision

By 2026, through qualitative and quantitative improvement of products, the company will remain a leader in the production of various types of sterile injectable pharmaceutical products in the domestic market, and while expanding in neighboring countries and penetrating new foreign markets, it will also start activity in the production of non-injectable pharmaceutical forms.

Services (21)

• Ipratropium and Salbutamol Inhalation Solution 0.5 mg and 2.5 mg/2.5 mL
• Salbutamol 2.5 mg/2.5 mL
• Sodium Bicarbonate 4.2%
• Sodium Chloride 0.9%
• Linezolid 0.2%
• Potassium Chloride 0.15% in Dextrose 5%
• Potassium Chloride 0.3% in Dextrose 5%
• Ipratropium & Salbutamol (0.5mg + 2.5mg)/2.5mL
• Salbutamol 2.5mg/2.5mL
• Fluconazole 0.2%
• Levofloxacin 0.5%
• Ciprofloxacin 0.2%
• Metronidazole 0.5%
• Sodium Bicarbonate 7.5%
• Sodium Bicarbonate 8.4%
• Glycine 1.5% Irrigation Solution
• Sodium Chloride 0.9% Irrigation Solution
• Sodium Chloride 0.45%
• Dextrose 3.33% and Sodium Chloride 0.3%
• Dextrose 5% and Sodium Chloride 0.45%
• Dextrose 5% and Sodium Chloride 0.9%